Total Funding
$9.3M
Employee Range
501-1000
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.
Hemosphere data powered by:
Share
Hemosphere data powered by:
HemosphereOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
HemosphereIndustry Rankings in
Healthtech
City Rank
Share
1st
In Kennesaw
Top 50%out of 2 startups
National Rank
Share
2,016th
In United States
Top 23%out of 8869 startups
Regional Rank
Share
2,112th
In North America
Top 22%out of 9671 startups
HemosphereSubindustry Rankings in
Health CareCity Rank
Share
1st
In Kennesaw
Top 100%out of 1 startups
National Rank
Share
871st
In United States
Top 22%out of 4101 startups
Regional Rank
Share
920th
In North America
Top 21%out of 4449 startups
rankings by:
HemosphereSB Rank Evolution
Not enough data points to display the chart.
HemospherestartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro